Back

Global mRNA 3'UTR lengthening in small-cell neuroendocrine carcinoma

Zhang, Y.; Zhao, X.; Wang, H.; Hu, Y.-M.; Sun, X.-X.; Zhao, F.; Du, S.; Dai, R. S.; Andeen, N. K.; Sears, R. C.; Corey, E.; Brody, J. R.; Alumkal, J. J.; Mills, G. B.; Nelson, P. S.; DAI, M.; Xia, Z.

2026-01-28 cancer biology
10.64898/2026.01.26.701900 bioRxiv
Show abstract

Small-cell neuroendocrine carcinoma (SCNC) is a rare but highly malignant tumor subtype that primarily arises in the lung, also rarely in other organs, and as a consequence of treatment induced lineage transdifferentiation of prostate adenocarcinomas. The molecular convergence of SCNC across diverse tissues enables its identification through conserved SCNC-specific molecular markers, facilitating tumor subtype classification. As a critical post-transcriptional regulatory mechanism, alternative polyadenylation (APA) modulates 3'UTR length and significantly impacts tumor progression. However, its role in SCNC remains largely unclear. Here, we report a global 3'UTR lengthening pattern driven by APA in SCNC. We identified a set of conserved 3'UTR lengthening events across SCNCs of different tissue origins, which are strongly associated with neural development and related signaling pathways. Furthermore, we developed a neural network-based prediction model to classify SCNC by leveraging these specific APA signatures. Our study provides new insights into the post-transcriptional landscape of SCNCs and highlights APA signatures as promising biomarkers for SCNC identification.

Matching journals

The top 11 journals account for 50% of the predicted probability mass.

1
Protein & Cell
25 papers in training set
Top 0.2%
7.1%
2
Genome Medicine
154 papers in training set
Top 1.0%
6.3%
3
Genomics, Proteomics & Bioinformatics
171 papers in training set
Top 1%
6.3%
4
Molecular Cancer
14 papers in training set
Top 0.1%
6.3%
5
Cell Reports
1338 papers in training set
Top 11%
4.3%
6
eLife
5422 papers in training set
Top 22%
3.9%
7
Nature Communications
4913 papers in training set
Top 40%
3.6%
8
Cell Discovery
54 papers in training set
Top 1%
3.6%
9
iScience
1063 papers in training set
Top 5%
3.6%
10
Advanced Science
249 papers in training set
Top 6%
3.6%
11
Communications Biology
886 papers in training set
Top 3%
3.1%
50% of probability mass above
12
Signal Transduction and Targeted Therapy
29 papers in training set
Top 0.4%
2.6%
13
Scientific Reports
3102 papers in training set
Top 50%
2.1%
14
Cell Genomics
162 papers in training set
Top 2%
2.1%
15
Gastroenterology
40 papers in training set
Top 1%
1.7%
16
National Science Review
22 papers in training set
Top 0.9%
1.7%
17
Cancer Research
116 papers in training set
Top 2%
1.7%
18
PLOS ONE
4510 papers in training set
Top 55%
1.7%
19
Nucleic Acids Research
1128 papers in training set
Top 11%
1.7%
20
Computational and Structural Biotechnology Journal
216 papers in training set
Top 6%
1.2%
21
Frontiers in Oncology
95 papers in training set
Top 3%
1.2%
22
Cancer Cell
38 papers in training set
Top 1%
1.2%
23
PLOS Computational Biology
1633 papers in training set
Top 21%
0.9%
24
Neoplasia
22 papers in training set
Top 0.5%
0.9%
25
Cancers
200 papers in training set
Top 4%
0.8%
26
Oncogene
76 papers in training set
Top 2%
0.8%
27
PLOS Biology
408 papers in training set
Top 18%
0.8%
28
Science China Life Sciences
26 papers in training set
Top 2%
0.8%
29
PLOS Genetics
756 papers in training set
Top 15%
0.7%
30
Science Advances
1098 papers in training set
Top 30%
0.7%